Source: Eur Respir J 2012; 40: 448-454
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Chapman Eleanor A., Thomas Paul S., Stone Emily, Lewis Craig, Yates Deborah H.. A breath test for malignant mesothelioma using an electronic nose. Eur Respir J 2012; 40: 448-454

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds increase the likelihood of detecting malignant pleural mesothelioma Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009 Chemical characterization of exhaled breath to discriminate patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010 Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma. Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Exhaled breath to screen for malignant pleural mesothelioma: a validation study Source: Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017 Year: 2017 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis Source: Eur Respir J 2006; 27: 929-936 Year: 2006 Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Drug repurposing in malignant pleural mesothelioma: a breath of fresh air? Source: Eur Respir Rev, 27 (147) 170098; 10.1183/16000617.0098-2017 Year: 2018 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 An Investigation into the ability of people with lung disease to provide breath specimens using a roadside screening device and an evidential breath testing device. Source: International Congress 2017 – Lung function testing Year: 2017 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 The electronic nose: emerging biomarkers in lung cancer diagnostics Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019 Year: 2019 Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Exhaled volatile organic compounds as biomarkers for respiratory diseases Source: Eur Respir Monogr 2010; 49: 130-139 Year: 2010